Sleep drug tested to fight opioid cravings
NCT ID NCT05829655
Summary
This early-stage study is testing whether suvorexant, a medication approved for insomnia, might help people with opioid addiction by reducing their desire to use drugs. About 75 participants with opioid use disorder will stay in a hospital for about two weeks. They will receive either the study drug or a placebo to see if it changes how much they want or use opioids.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
General Clinical Research Center
Baltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.